Clinical Trials Management System (CTMS) “OnCore”

Jan 4, 2021 | Conduits News

ConduITS the Clinical & Translational Science Award at Mount Sinai received an administrative supplement from NCATS the NIH center that funds the CTSA program in August of 2018 to implement a system-wide Clinical Trials Management System (CTMS) “OnCore”. The Office of Research Services (ORS) within ConduITs is implementing the CTMS. OnCore will standardize clinical research (C/R) oversight in research compliance, billing and the conduct of C/R trials, allow institution-wide reporting of C/R metrics, and centralize access to the ISMMS research portfolio improving the management of Clinical Trials conducted at the Mount Sinai Health System.

In March of 2020, the enterprise roll-out of OnCore CTMS was put on hold due to the COVID-19 pandemic as most study personnel were deployed to assist with the pandemic as non-essential research was put on hold. ORS pivoted the focus of the system-wide implementation toward the use of OnCore to manage COIVD-19 clinical trials. This allowed the ORS to enhance the management of the COVID-19 Protocol Review Committee and disseminate a list of active COVID-19 clinical trials to clinicians across the health system. The ORS is currently working with the Epic team to develop a report of patients enrolled in COVID-19 to reduce redundancies in matching eligible patients to active studies.

The ORS also used the time to develop enhanced and remote e-learning and training resources for OnCore. With the help of Levy Library, the OnCore CTMS End-User Training eLearning Modules were created using the software Camtasia and were tailored to the Mount Sinai research community. As we adjusted to the “new normal”, these eLearning modules expedited the process of training new users. This allowed study teams adjusting to different schedules and working remotely to have access to the training resources at any time.

In late August when the enterprise roll-out resumed, the eLearning Modules became a pre-requisite for teams to complete prior to Go-Live Training conducted via Zoom. Prior to the development of the eLearning modules, Go-Live Training would typically take an entire work day, but has now has turned into a 2 ½ hour live training session. In addition to the resumption of the enterprise roll-out of OnCore CTMS, ORS has begun the process of collaborating with the Tisch Cancer Institute by assisting with the Clinical Research Coordinator Training in OnCore CTMS.

Anticipated date of completion of the enterprise roll-out is May 2021.

The OnCore CTMS End-User Training eLearning Modules are expected to be available in PEAK by December of 2021.

If you have any questions or want to read about updates to the OnCore role out contact Research411 or go to The Research Roadmap.

ConduITS is supported by NCATS of the NIH’s CTSA Program. Any use of CTSA-supported resources requires citation of grant number UL1TR001433 awarded to ISMMS in the acknowledgment section of every publication resulting from this support. Adherence to the NIH Public Access Policy is also required.

 

 

 

Recent ConduITS News

What is the Mount Sinai Exposomics Core?

The Mount Sinai Exposomics Core centers around The Institute for Exposomic Research at the Icahn School of Medicine at Mount Sinai, which was established in 2017 under the leadership of Robert O. Wright, MD, MPH and Rosalind J. Wright, MD, MPH, international leaders...

read more

What does the Exposomics Core do?

The Exposomics Core is at the cutting edge of research to quantify the exposome (i.e., nutrition, social risk factors, and chemical exposure) via lab assays, geospatial modeling, data mining and artificial intelligence. We disseminate our work to cultivate the public...

read more

Highlighted Exposomics Core Events

In 2025, the Exposomics Core was a part of multiple events, including: Lunchtime Chat Webinars (held throughout the year) On January 8, 2025, Maayan Yitshak-Sade, PhD, MPH (Associate Professor, Department of Environmental Medicine, Icahn School of Medicine at Mount...

read more

Exposomics Core Highlighted Information

More information on faculty and staff updates can be found in the departmental newsletters, which are sent out throughout the year. Below are the most recent editions from 2025: December 2025 July 2025 April 2025 The Institute for Exposomic Research is also on...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Dr. Lee 2025 KL2 Scholar

Dr. Lee 2025 KL2 Scholar

Dr. Lee is an Assistant Professor in the Division of Surgical Oncology. Her proposal is titled ‘Generating a Multimodal Machine Learning Model for Prediction of Thyroid Cancer Recurrence’. Her mentors will be: Girish Nadkarni, MD, MPH, Michael Marin, MD, and Gerald...

read more
Dr. Xiaoqi 2025 KL2 Scholar

Dr. Xiaoqi 2025 KL2 Scholar

Dr. Xiaoqi is an Assistant Professor in the Department of Immunology and Immunotherapy. His proposal is titled ‘Nanoparticle STING Immunotherapy Against TP53-Mutated Acute Myeloid Leukemia’. His mentors will be: Brian Brown, PhD, and Joshua Brody, MD.  Dr. Xiaoqi is...

read more